(123)I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations

Reduced uptake of (123)I- metaiodobenzylguanidine (MIBG) on cardiac gammagraphy and impaired odor identification are markers of neurodegenerative diseases with Lewy bodies (LB) as a pathological hallmark, such as idiopathic Parkinson’s disease (IPD). LRRK2 patients present with a clinical syndrome i...

Descripción completa

Detalles Bibliográficos
Autores principales: Valldeoriola, Francesc, Gaig, Carles, Muxí, Africa, Navales, Ignacio, Paredes, Pilar, Lomeña, Francisco, De la Cerda, Andres, Buongiorno, Mariateresa, Ezquerra, Mario, Santacruz, Pilar, Martí, Maria Jose, Tolosa, Eduardo
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101340/
https://www.ncbi.nlm.nih.gov/pubmed/21221623
http://dx.doi.org/10.1007/s00415-010-5896-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101340/
https://www.ncbi.nlm.nih.gov/pubmed/21221623
http://dx.doi.org/10.1007/s00415-010-5896-6

Ejemplares similares